WSA A/S (WS Audiology)

Denmark · owned by T&W Medical A/S (Denmark) · wsa.com · 28 vendors

WS Audiology (WSA) is a global leader in hearing healthcare, designing and manufacturing innovative hearing aids under multiple brands including Signia, Widex, Rexton, and Audio Service. The company helps millions of people with hearing loss regain the ability to hear, operating across more than 130 markets with over 12,000 employees worldwide. WSA is headquartered in Lynge, Denmark, and is registered under Danish CVR number 40296638.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-13 · revision 4

28 direct vendors, 301 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 0/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

I am unable to gather specific, verified information about 'https://wsa.com' as I do not have access to real-time web browsing or external databases. Therefore, I cannot provide a migration readiness score or a detailed assessment based on the requested criteria. All data points required for the assessment (Products Offered, Internal Tech Stack, Geographic Distribution, Revenue Distribution, Workforce Distribution, Regulatory Environment, Data Residency, Financial Stability) are unavailable to me.

Compliance

7 in-scope frameworks identified; showing 3.

SOC 2 (source) — Assessment Required

While not a direct regulatory mandate, lack of SOC 2 attestation can hinder business relationships, especially with enterprise clients or partners who require such assurances for data security and privacy. It can also indicate potential weaknesses in internal controls, increasing operational and reputational risk, particularly for a company handling sensitive health data and operating globally.

Evidence: https://www.aicpa.org/interestareas/frc/assuranceadvisoryservices/aicpasoc2report.html

US FDA Regulations for Medical Devices — Assessment Required

Non-compliance with FDA regulations can result in product recalls, import bans, warning letters, civil penalties, criminal prosecution, and significant damage to reputation and market access in the US. The FDA's oversight is comprehensive and strict, making compliance critical for operations in the United States.

Evidence: https://www.fda.gov/medical-devices, https://wsa.com/en-us/about-us/our-company

EU Medical Device Regulation — Assessment Required

Non-compliance with MDR can lead to severe consequences, including market withdrawal of products, inability to place new products on the market, significant fines, legal action, and severe reputational damage. The MDR has stringent requirements for clinical evidence, quality management systems, post-market surveillance, and technical documentation, making compliance complex and critical for market access in the EU.

Evidence: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745, https://wsa.com/en-us/about-us/our-company

Financials

Three-year financials

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report